Q1 2026. Management View. Brian Lian said the quarter’s operational focus was advancing VK2735 across multiple Phase III-enabl ...

After a phase of strong growth and margin expansion, Shaily Engineering Plastics is entering a more demanding phase. The ...

The FDA has approved a self-administered autoinjector form of anifrolumab for the treatment of systemic lupus erythematosus, ...

Following a turbulent year for the markets in general and biotech in particular, the industry made a notable recovery, ...

Anifrolumab-fnia, an IFNAR1-blocking monoclonal antibody, is now authorized for weekly subcutaneous self-administration in ...

AstraZeneca’s SAPHNELO ® (anifrolumab-fnia) has been approved in the US for self-administration as a once-weekly autoinjector ...

Viking Therapeutics reported Q1 2026 progress on its obesity drug VK2735, completing VANQUISH-2 enrollment and expanding a maintenance dosing study to eight arms. The company now plans to start the ...

Children at risk of anaphylaxis are still not consistently protected in schools , despite clear medical guidance. That was ...

Gemini CLI CVSS 10.0 flaw in versions below 0.39.1 enabled RCE in CI workflows, forcing Google to mandate explicit workspace ...

A joint security team has arrested a 20-year-old auto driver along with a large quantity of drugs from the Gaur customs area ...

New Delhi, Apr 29 (PTI) Dr Reddy’s Laboratories on Wednesday said it has received a notice of compliance (NOC) from Health Canada for its generic semaglutide injection indicated for the management of ...

Renault is preparing the Bridger SUV for India with a new 1.2-litre petrol engine and multiple powertrain options ...